Yahoo
NasdaqCM - Delayed Quote USD

Pasithea Therapeutics Corp. (KTTAW)

0.0028 +0.0028 (0.00%)
At close: September 15 at 2:22:57 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Cost of Revenue
--
--
--
--
113.1950
Gross Profit
--
--
--
--
373.3640
Operating Expense
23,956.1430
20,857.2950
14,249.9620
15,979.3610
12,588.9710
Operating Income
-23,956.1430
-20,857.2950
-14,249.9620
-15,979.3610
-12,588.9710
Net Non Operating Interest Income Expense
1,086.2780
327.1930
423.1840
415.3680
0
Other Income Expense
1,578.2430
102.4190
-77.8060
56.2450
861.0860
Pretax Income
-21,291.6220
-20,427.6830
-13,904.5840
-15,507.7480
-11,727.8850
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-21,291.6220
-20,427.6830
-13,904.5840
-15,961.6580
-13,936.4520
Diluted NI Available to Com Stockholders
-21,291.6220
-20,427.6830
-13,904.5840
-15,961.6580
-13,936.4520
Total Operating Income as Reported
-23,956.1430
-20,857.2950
-14,249.9620
-15,979.3610
-12,588.9710
Total Expenses
23,956.1430
20,857.2950
14,249.9620
15,979.3610
12,588.9710
Net Income from Continuing & Discontinued Operation
-21,291.6220
-20,427.6830
-13,904.5840
-15,961.6580
-13,936.4520
Normalized Income
-22,446.4320
-20,153.7417
-13,826.7780
-15,563.9930
-12,578.3380
Interest Income
1,086.2780
327.1930
423.1840
415.3680
0
Interest Expense
--
--
--
--
0.1020
Net Interest Income
1,086.2780
327.1930
423.1840
415.3680
0
EBIT
-23,956.1430
-20,857.2950
-14,249.9620
-15,979.3610
-12,588.9710
EBITDA
-23,301.9280
-20,194.7100
-13,600.9330
-15,330.9070
-12,583.8770
Reconciled Cost of Revenue
--
--
--
--
113.1950
Reconciled Depreciation
654.2150
662.5850
649.0290
648.4540
5.0940
Net Income from Continuing Operation Net Minority Interest
-21,291.6220
-20,427.6830
-13,904.5840
-15,507.7480
-11,727.8850
Total Unusual Items Excluding Goodwill
1,154.8100
-278.1130
-77.8060
56.2450
850.4530
Total Unusual Items
1,154.8100
-278.1130
-77.8060
56.2450
850.4530
Normalized EBITDA
-24,456.7380
-19,916.5970
-13,523.1270
-15,387.1520
-13,434.3300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-4.1717
0
0
0
12/31/2022 - 7/17/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: